Calza L, Legnani G, Fulgaro C, Verucchi G, et al. CHANGES IN SERUM INFLAMMATORY MARKERS IN ANTIRETROVIRAL THERAPY-NAIVE HIV-INFECTED PATIENTS STARTING DOLUTEGRAVIR/LAMIVUDINE OR DOLUTEGRAVIR/LAMIVUDINE/ABACAVIR. J Acquir Immune Defic Syndr 2021 Nov 5. pii: 00126334-900000000-95763.
PMID: 34743087